Teva Pharmaceutical Industries Newsroom

Barclays Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Maintains Target Price $22

Futu NewsSep 24 18:32

Barclays Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Maintains Target Price $22

Futu NewsSep 24 15:32

Jefferies Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Maintains Target Price $23

Futu NewsSep 23 20:33

BofA Securities Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Announces Target Price $22

Futu NewsSep 19 22:31

Jefferies Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Maintains Target Price $23

Futu NewsSep 9 20:33

UBS Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Maintains Target Price $26

Futu NewsSep 9 16:31

Organon Downgraded, Amneal Upgraded as J.P. Morgan Reviews Specialty Pharma

Seeking AlphaSep 6 20:42

UBS Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Raises Target Price to $26

Futu NewsSep 3 22:31

Piper Sandler Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Raises Target Price to $23

Futu NewsAug 28 20:33

BofA Securities Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating

Futu NewsAug 22 23:31

Barclays Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Maintains Target Price $22

Futu NewsAug 5 16:32

Argus Research Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating

Futu NewsAug 2 23:31

Evercore Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating

Futu NewsAug 2 20:31

Barclays Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Raises Target Price to $22

Futu NewsAug 2 16:33

Teva Pharmaceutical Indus Analyst Ratings

BenzingaAug 2 00:52

BofA Securities Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Maintains Target Price $21

Futu NewsAug 1 18:36

Piper Sandler Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Maintains Target Price $20

Futu NewsJul 24 19:33

Teva Pharmaceutical Indus Analyst Ratings

BenzingaJul 11 10:12

UBS Maintains Buy on Teva Pharmaceutical Indus, Raises Price Target to $24

BenzingaJul 11 10:12

Argus Upgrades Teva to Buy, Cites Recent Drug Approvals

Seeking AlphaJul 11 01:19